Market Newsdesk

SHOUGUANG, China, April 08, 2021 (GLOBE NEWSWIRE) — Gulf Resources, Inc. (Nasdaq: GURE) (“Gulf Resources”, “we,” or the “Company”), a leading manufacturer of bromine, crude salt and specialty chemical products in China, today announced financial results for the fourth quarter and full fiscal year 2020 ended December 31, 2020.

Highlights:

• First profitable quarter in three years
• Positive cash flow from operations
• Strong balance sheet. Large cash reserves
• Rising price of bromine and expected completion of the new Yuxin Chemical Factory in 2021 supports increasingly optimistic view of the future.

Fourth Quarter 2020 Financial Results

Despite the facts that our new chemical factory is still under construction, our trial production at our natural gas well in Sichuan has to be temporarily halted, only 4 of our 7 bromine and crude salt factories are open, the government forced the seasonal closing of all factories from December 25, 2020 to February 19, 2021, and winter is normally the slowest production season of the year because of the temperature, Gulf Resources was still able to record the first profitable quarter in the past three years since the initiation of the original shutdown for rectification and environmental improvement.

Full Year and 4 TH Quarter Results(Expressed in U.S. dollars)
		2020 (A)		9 Months (B)		Q4-2020 (C)
NET REVENUE		28,207,024		16,399,338		11,807,686
OPERATING EXPENSE
Cost of net revenue		19,415,034		12,694,271		6,720,763
Sales, marketing and other operating expenses		42,663		28,866		13,797
Direct labor and factory overheads incurred during plant shutdown		8,170,390		6,886,215		1,284,175
General and administrative expenses		10,239,943		7,297,010		2,942,933
Other operating expense		22,386		15,775		6,611
Total Expenses		37,890,416		26,922,137		10,968,279
Income (Loss) from Operations		(9,683,392	)	(10,522,799	)	839,407
Interest		154,877		114,089		40,788
Income (Loss) Before Taxes		(9,528,515	)	(10,408,710	)	880,195

(A)   Information represents are audited by company auditor
(B)   “The 9 months” represents the financial results for the nine months ended September 30, 2020 as filed in the 10-Q on November 16, 2020.
(C)    C=A-B

These results also include $1,284,175 of direct labor and factory overheads incurred during the plant shutdowns in 4^th quarter. If this total is added back to our income, our operating businesses would earned $2,164,370 during the fourth quarter.

During the 4^th quarter, our bromine business, despite the early closure for Chinese New Year, recorded income from operations before corporate costs of almost $4 million. Our chemical business, which is under construction, recorded loss from operations before corporate costs of $706,359. Our natural gas business recorded loss from operations before corporate costs of $53,848, and our crude salt business recorded loss from operations before corporate costs of $980,162. As we have noted, the winter season is always a weak season for our crude salt business. It is difficult to process and mine crude salt when temperatures are too low.

Income (Loss) from Operations
Segment:				Fiscal Year 2020		9 Months		Q4
Bromine				1,616,542		(2,383,260	)	3,546,757
Crude Salt				(3,589,494	)	(2,609,332	)	(527,117	)
Chemical Products				(2,745,297	)	(2,038,938	)	(706,359	)
Natural Gas				(204,514	)	(150,666	)	(53,848	)
Loss from operations before corporate costs				(4,922,763	)	(7,182,196	)	2,259,433

We believe we reached good profitability in our bromine business during this quarter.

In the 4th Quarter, we generated cash from operations of $6,047,617 compared to cash used in operations of $2,988,472 in the previous year, an improvement of $9,036,089 over the results from the previous year.

As the Chinese economy continues to recover and production has resumed after the Chinese New Year, the price of bromine has continued to increase. Based on monthly prices from CEIC Data Group (ceicdata.com) and spot prices from Sunsirs Commodity Data Group (sunsirs.com), the price of bromine on April 5, 2021 was RMB 36,222 per ton. This is an increase of 23.5% from Q2 2020, 29.3% from Q3 2020, and 11.4% from Q4 2020.

Bromine Prices In China
Period	Price	Change to 4/5/21
Q2-2020	29,333	23.5%
Q3-2020	28,017	29.3%
Q4-2020	32,087	11.4%
Q1-2021	34,493	4.8%
4/5/21	36,222

With the current level of bromine prices, we are optimistic about the future in our bromine segment.

We are working with the local authorities in Shandong Province to finalize the issues related to our three remaining bromine and crude salt factories. While we may have to build additional aqueducts, wells and secure additional land for our salt ponds, we remain optimistic that we will receive approvals to reopen these facilities in 2021.

We are also making progress in the construction of our Yuxin Chemical factory. We expect to have construction completed around June 2021. We will install the machinery and test the equipment during the remainder of the year and expect to begin trial production by the start of 2022. While this new factory will be smaller than the combined two old factories, the Company expects it to make higher net profit margin as we plan to focus more on the higher margin pharmaceutical intermediate products. We are optimistic by the progress we are making on constructing our new factories. Management expects to continue to post photos on its website so investors can track the progress of the construction of the chemical factories.

We also remain optimistic about the opportunities for our natural gas and brine business in Sichuan Province. We are working with the governments of Tianbao Town, Daying County, and Sichuan Province in China closely, and plan to proceed with its applications for the natural gas and brine project approvals with related government departments after the government has finalized the land and resources planning for Sichuan Province.

Full Year 2020 Financial Results

In 2020, net revenues increased 166% to $28,207,024. Gross profits increased 70% to $8,791,990. This loss included $8,170,390 of direct labor and factory overheads incurred during the plant shutdown. G&A expenses declined 23% to $10,239,943. Our loss from operations declined 58% to $9,683,392. Our net loss declined 67% to $8,420,044. We lost $0.87 per share compared to $2.73 per share in 2019.

Cash Flow

Our cash flow showed significant improvement. We generated net cash from operations of $9,305,627 compared to net cash used in operations of $15,309,112 in 2019.

During 2020, we purchased $21,719,369 of property, plant, and equipment. Of this total, $17,914,948 was for our new Yuxin Chemical factory, $3,157,669 was for our bromine business, and $646,752 was for our crude salt business.

Capital Expenditures

In 2020, we spent $21,719,369 compared to $60,611,949 in 2019 on property, plant and equipment. This includes major investments in our new Yuxin Chemical Factory, new bromine and crude salt factories, and newly drilled wells.

Balance Sheet

Our balance sheet remains strong. At Dec. 31, 2020,

• Cash equaled $94,222,538
• Cash per share equaled $9.43*
• Net cash (cash minus all liabilities) equaled $77,208,993
• Net cash per share equaled $7.72*
• Current assets equaled $107,310,965
• Current liabilities equaled $7,102,300
• Working capital equaled $100,208,665
• [Working capital per share equaled $10.02*
• Shareholders’ equity equaled $277,024,273
• Shareholders’ equity per share equaled $27.71*

With our strong balance sheet, the Company expects to be able to complete construction of its Yuxin chemical factory, open its remaining bromine and crude salt facilities, drill new wells, restore operations in Sichuan province, and acquire more bromine and downstream chemical facilities.

Commentary

Mr. Xiaobin Liu, the CEO of Gulf Resources stated. “We are very pleased to have delivered a profitable quarter to our shareholders. The last three years have been very long and painful. The process of improving the environment and protecting the people of China is extremely complex. At the time our factories were first closed, we also did not expect the destruction we saw from TyhoonLekima, the most destructive typhoon to hit China.”

“Now,” Mr. Liu further stated, “most of the problems are behind us. We have 4 bromine and crude salt factories in operation. The price of bromine is nearing historic highs. We expect the price of bromine to remain high because demand is increasing, especially with COVID, and there are lesser competitors. As we have noted, many of the smaller companies did not have the capital to complete rectification. We also expect to receive the approvals for these bromine and salt factories in the second half of 2021. However, there is no assurance that we will be able to obtain the approvals necessary to operate those factories from the government.”

“Construction on our new chemical factory is on schedule,” Mr. Liu added. “We expect this factory will make higher net profit margin as we plan to focus more on the higher margin pharmaceutical intermediate products. As with Yuxin Chemical Factory, many chemical factories have been permanently closed, with less competition, more demand, and new equipment, we are very excited about the opportunities in chemicals. We are also committed to our natural gas and brine project in Sichuan, Petro-China has made one of the largest natural gas discoveries in Chinese history in the same town as our well. The Company plans to proceed with its applications for the natural gas and brine project approvals with related government departments after the governmental planning has been finalized.”

“I would like to thank our management, our employees, and our shareholders for their patience during this extremely trying period,” Mr. Liu continued. “In September 2017, I could not have understood how many different problems we would have to address. Now, however, we have excellent visibility towards the future, and what we see is very exciting. We believe we are in a position to produce earnings for our company once all our facilities are back in operation.”

“Finally,” Mr. Liu concluded. “We are working hard to respond to the requests of our shareholders. We have updated our website and will continue to make improvements. We appreciate you support and hope to have continuing positive news.

(*These calculations are based on the number of shares outstanding of 9,997,477 shares
 as of December 31, 2020)

Conference Call

Gulf Resources management will host a conference call on Friday, April 9, 2021 at 08:00 AM EDT to discuss financial results for fourth quarter and full year 2020.

Mr. Xiaobin Liu, CEO of Gulf Resources, will be hosting the call. The Company management team will be available for investor questions following the prepared remarks. 

To participate in this live conference call, please dial +1 (877) 407-8031 five to ten minutes prior to the scheduled conference call time. International callers should dial +1 (201)689-8031, and please reference to “Gulf Resources” while dial in.

The webcasting is also available then, just simply click on the link below:
http://www.gulfresourcesinc.com/events.html

A replay of the conference call will be available two hours after the call’s completion during 04/09/202111:00 ET – 04/16/202111:00 ET. To access the replay, call +1 (877) 481-4010. International callers should call +1 (919) 882-2331. The Replay Passcode is 40701.

About Gulf Resources, Inc.

Gulf Resources, Inc. operates through three wholly-owned subsidiaries, Shouguang City Haoyuan Chemical Company Limited (“SCHC”), ShouguangYuxin Chemical Industry Co., Limited (“SYCI”), and Daying County Haoyuan Chemical Company Limited (“DCHC”). The Company believes that it is one of the largest producers of bromine in China. Elemental Bromine is used to manufacture a wide variety of compounds utilized in industry and agriculture. Through SYCI, the Company manufactures chemical products utilized in a variety of applications, including oil and gas field explorations and papermaking chemical agents, and materials for human and animal antibiotics. DCHC was established to further explore and develop natural gas and brine resources (including bromine and crude salt) in China. For more information, visit www.gulfresourcesinc.com.

Forward-Looking Statements

Certain statements in this news release contain forward-looking information about Gulf Resources and its subsidiaries business and products within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. The actual results may differ materially depending on a number of risk factors including, but not limited to, the general economic and business conditions in the PRC, the risks associated with the COVID-19 pandemic outbreak, future product development and production capabilities, shipments to end customers, market acceptance of new and existing products, additional competition from existing and new competitors for bromine and other oilfield and power production chemicals, changes in technology, the ability to make future bromine asset purchases, and various other factors beyond its control. All forward-looking statements are expressly qualified in their entirety by this Cautionary Statement and the risks factors detailed in the Company’s reports filed with the Securities and Exchange Commission. Gulf Resources undertakes no duty to revise or update any forward-looking statements to reflect events or circumstances after the date of this release.

CONTACT: Gulf Resources, Inc.

Web:	http://www.gulfresourcesinc.com
	Director of Investor Relations
	Helen Xu (Haiyan Xu)
	[email protected]

GULF RESOURCES, INC.
AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(Expressed in U.S. dollars)

		December 31, 2020				December 31, 2019
Current Assets
Cash		$	94,222,538			$	100,301,986
Accounts receivable			6,521,798				4,877,106
Inventories, net			419,609				690,087
Prepayments and deposits			6,146,461				1,332,970
Prepaid land leases			—				—
Other receivables			559				559
Total Current Assets			107,310,965				107,202,708
Non-Current Assets
Property, plant and equipment, net			148,947,689				137,994,949
Finance lease right-of use assets			186,272				179,526
Operating lease right-of –use assets			8,868,661				8,817,884
Prepaid land leases, net of current portion			10,134,004				9,115,276
Deferred tax assets			18,590,227				15,940,642
Total non-current assets			186,726,853				172,048,277
Total Assets		$	294,037,818			$	279,250,985
Commitment and Contingencies
Liabilities and Stockholders’ Equity
Current Liabilities
Payable and accrued expenses		$	5,081,701			$	1,106,048
Retention payable			–				3,805,483
Taxes payable-current			1,326,179				779,623
Finance lease liability, current portion			217,070				198,506
Operating lease liabilities, current portion			477,350				416,604
Total Current Liabilities			7,102,300				6,306,264
Non-Current Liabilities
Finance lease liability, net of current portion			1,888,903				1,905,772
Operating lease liabilities, net of current portion			8,022,342				7,931,849
Total Non-Current Liabilities			9,911,245				9,837,621
Total Liabilities			17,013,545				16,143,885
Commitment and Contingencies			—				—
Stockholders’ Equity
PREFERRED STOCK; $0.001 par value; 1,000,000 shares authorized; none outstanding
COMMON STOCK; $0.0005 par value; 80,000,000 shares authorized; 10,043,307and 9,563,257 shares issued; and 9,997,477 and 9,517,427 shares outstanding as of December 31, 2020 and December 31, 2019			24,139				23,904
Treasury stock; 45,830 and 45,830  shares as of December 31, 2020 and December 31, 2019 at cost			(510,329	)			(510,329	)
Additional paid-in capital			97,435,316				95,043,388
Retained earnings unappropriated			151,388,356				159,808,400
Retained earnings appropriated			24,233,544				24,233,544
Accumulated other comprehensive income (loss)			4,453,247				(15,491,807	)
Total Stockholders’ Equity			277,024,273				263,107,100
Total Liabilities and Stockholders’ Equity		$	294,037,818			$	279,250,985

The accompanying notes are an integral part of these consolidated financial statements.

GULF RESOURCES, INC.
AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
(Expressed in U.S. dollars)
		Years Ended December 31,
		2020				2019
NET REVENUE		$	28,207,024			$	10,596,521
OPERATING EXPENSE
Cost of net revenue			(19,415,034	)			(5,430,269	)
Sales, marketing and other operating expenses			(42,663	)			(12,434	)
Direct labor and factory overheads incurred during plant shutdown			(8,170,390	)			(15,175,280	)
General and administrative expenses			(10,239,943	)			(13,272,921	)
Other operating expense			(22,386	)			—
			(37,890,416	)			(33,890,904	)
LOSS FROM OPERATIONS			(9,683,392	)			(23,294,383	)
OTHER INCOME (EXPENSE)
Interest expense			(136,430	)			(145,445	)
Interest income			291,307				446,770
LOSS BEFORE INCOME TAXES			(9,528,515	)			(22,993,058	)
INCOME TAX (EXPENSE) BENEFIT			1,108,471				(2,806,987	)
NET LOSS		$	(8,420,044	)		$	(25,800,045	)
COMPREHENSIVE INCOME (LOSS):
NET LOSS		$	(8,420,044	)		$	(25,800,045	)
OTHER COMPREHENSIVE INCOME (LOSS)
– Foreign currency translation adjustments			19,945,054				(5,013,759	)
COMPREHENSIVE INCOME (LOSS)		$	11,525,010			$	(30,813,804	)
BASIC AND DILUTED LOSS PER SHARE		$	(0.87	)		$	(2.73	)
BASIC AND DILUTED WEIGHTED AVERAGE NUMBER OF SHARES:			9,650,619				9,465,432

The accompanying notes are an integral part of these consolidated financial statements.

GULF RESOURCES, INC.
AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
(Expressed in U.S. dollars)
		Years Ended December 31,
		2020				2019
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss		$	(8,420,044	)		$	(25,800,045	)
Adjustments to reconcile net income to net cash (used in) provided by operating activities:
Interest on capital lease obligation			135,936				144,881
Depreciation and amortization			15,987,860				14,060,927
Unrealized translation difference			1,832,026				(421,657	)
Deferred tax asset			(1,108,471	)			2,746,770
Stock-based compensation expense			2,392,163				45,900
Shares issued from treasury stock for services			—				21,600
Changes in assets and liabilities
Accounts receivable			(1,161,704	)			(5,070,180	)
Other receivables			—				11,794
Inventories			292,101				(700,476	)
Prepayment and deposits			(6,925	)			14,166
Accounts and Other payable and accrued expenses			342,790				(102,963	)
Taxes payable			(449,915	)			(374,575	)
Prepaid land leases			(372,259	)			—
Operating lease			(157,931	)			114,746
Net cash provided by (used in) operating activities			9,305,627				(15,309,112	)
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of property, plant and equipment			(21,719,369	)			(60,611,949	)
Net cash used in investing activities			(21,719,369	)			(60,611,949	)
CASH FLOWS FROM FINANCING ACTIVITIES
Repayment of finance lease obligation			(264,976	)			(275,509	)
Net cash used in financing activities			(264,976	)			(275,509	)
EFFECTS OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS			6,599,270				(2,500,379	)
NET DECREASE IN CASH AND CASH EQUIVALENTS			(6,079,448	)			(78,696,949	)
CASH AND CASH EQUIVALENTS – BEGINNING OF YEAR			100,301,986				178,998,935
CASH AND CASH EQUIVALENTS – END OF YEAR		$	94,222,538			$	100,301,986

GULF RESOURCES, INC.
AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS (CONTINUED)
(Expressed in U.S. dollars)
		Years Ended December 31,
		2020				2019
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION
Cash paid during the year for:
Income taxes		$	—			$	—
Interest on finance lease obligation		$	136,774			$	149,286
Operating right-of-use assets obtained in exchange for lease obligations		$	—			$	8,241,818
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES
Purchase of Property, plant and equipment included in Payable and accrued expenses		$	3,537,644			$	3,515,132
Par value of common stock issued upon cashless exercise of options		$	—			$	379

The accompanying notes are an integral part of these consolidated financial statements.

 

ENGLEWOOD, Colo., April 08, 2021 (GLOBE NEWSWIRE) — Innospec Inc. (NASDAQ: IOSP) today announced that it will release first quarter 2021 earnings results on Tuesday, May 4, 2021, after market close. Following the release of its results, Patrick S. Williams, President and Chief Executive Officer, and Ian Cleminson, Executive Vice President and Chief Financial Officer, will host an interactive conference call on Wednesday, May 5, 2021, at 9.00a.m. ET.

The public is invited to listen to the conference call by dialing +1 877-870-9135 and +44 (0) 2071 928338 (International), 5-10 minutes prior to the start of the call. The access code is 1043957. An audio webcast of the conference call will run simultaneously on the company’s website at www.innospec.com. The relevant link as well as the slide presentation for the conference call will be found in the Investor Relations section of the website.

A replay of the call will be available from May 5, 2021 through May 12, 2021. The replay can be accessed by calling +1 866-331-1332 and +44 (0) 3333 009785 (International). The access code for the replay is 1043957. A replay of the webcast can also be accessed from the company’s website and will be available for 30 days following the call.

About Innospec Inc.

Innospec Inc. is an international specialty chemicals company with approximately 1900 employees in 23 countries. Innospec manufactures and supplies a wide range of specialty chemicals to markets in the Americas, Europe, the Middle East, Africa and Asia-Pacific.  The Fuel Specialties business specializes in manufacturing and supplying fuel additives that improve fuel efficiency, boost engine performance and reduce harmful emissions. Oilfield Services provides specialty chemicals to all elements of the oil & gas exploration and production industry.  The Performance Chemicals business creates innovative technology-based solutions for our customers in the Personal Care, Home Care, Agrochemical, Mining and Industrial markets. Octane Additives produces octane improvers to enhance gasoline.

Forward-Looking Statements

This press release contains certain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995.  All statements other than statements of historical facts included or incorporated herein may constitute forward-looking statements.  Such forward-looking statements include statements (covered by words like “expects,” “estimates,” “anticipates,” “may,” “believes,” “feels” or similar words or expressions, for example) which relate to earnings, growth potential, operating performance, events or developments that we expect or anticipate will or may occur in the future.  Although forward-looking statements are believed by management to be reasonable when made, they are subject to certain risks, uncertainties and assumptions, and our actual performance or results may differ materially from these forward-looking statements.  Additional information regarding risks, uncertainties and assumptions relating to Innospec and affecting our business operations and prospects are described in Innospec’s Annual Report on Form 10-K for the year ended December 31, 2020 and other reports filed with the U.S. Securities and Exchange Commission.  You are urged to review our discussion of risks and uncertainties that could cause actual results to differ from forward-looking statements under the heading “Risk Factors” in such reports.  Innospec undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Contacts:

Corbin Barnes
Innospec Inc.
+44-151-355-3611
[email protected]

DRAPER, Utah, April 08, 2021 (GLOBE NEWSWIRE) — HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity”), the nation’s largest independent health savings account (“HSA”) custodian, today announced that it had entered into a definitive agreement to acquire Further, a leading provider of HSA and consumer directed benefit administration services, and the nation’s ninth largest HSA custodian overall.

The acquisition of Further and its technology expands HealthEquity’s leadership in the growing HSA market, enhances its ability to drive growth with health plans and other go-to-market partners, and adds to its Total Solution offering of remarkable products backed by trademark Purple service, education and engagement to help working families connect health and wealth.

Expanded HSA Leadership

With Further’s approximately 550,000 HSA customers and $1.7 billion HSA assets under its custody, HealthEquity will grow to approximately 6.3 million HSA Members and more than $16 billion in HSA Assets, adding to its position as the leading health savings custodian nationwide. The acquisition also immediately expands HealthEquity’s health plan footprint, particularly its commitment to not-for-profit health plans. Further also brings approximately 28,000 employer clients and over 300,000 consumer-directed benefit accounts (CDBs), including FSAs, HRAs and VEBAs.

Technology-Driven Partner Growth

Further’s private-label HSA and CDB solutions, deployed in the cloud, expand HealthEquity’s reach to a growing network of health plan, retirement plan, benefits administration, and other go-to-market partners. “By putting HealthEquity’s Total Solution inside of network partner applications and private-label brand environments, Further’s technology will align us more closely than ever before and enable new partnerships to introduce more consumers to HSAs,” said President and CEO Jon Kessler.

New VEBA Administration Capability

Further is also a technology leader in employer-funded Voluntary Employees’ Beneficiary Association (VEBA) trust administration. VEBAs are triple-tax advantaged health accounts like HSAs, that cover medical costs while employed or post-retirement. VEBAs are not restricted to those in high-deductible health plans. “Adding VEBA capability to HealthEquity’s Total Solution brings a new choice to clients and partners seeking to offer differentiated benefits while controlling healthcare costs,” added Kessler.

A Legacy of Care

Further is part of Stella Health, a Minnesota-based family of companies committed to reinventing health care to improve health for the people it serves. In addition to Further, the Stella family includes Minnesota’s largest non-profit health plan; supportive medical care services; and a number of other subsidiary and affiliate companies. “For more than thirty years, Further has been helping people seamlessly manage their money, health and life,” said Jay Matushak, senior vice president and CFO of Stella. “We know our partners, employers, members and associates will be in great hands with HealthEquity. Their commitment to innovation, customer service and value is well-known and highly regarded within the HSA industry. With Stella placing a greater strategic emphasis on developing new care delivery models, HealthEquity was the ideal company to carry on Further’s legacy of helping people spend and save wisely on their health care.”

Financial Details

HealthEquity is purchasing Further for $500 million. At closing, management expects the transaction to add approximately $60 million in revenue on an annualized run-rate basis, with a 20% contribution to adjusted EBITDA margin. Management expects to achieve an additional $15 million in efficiencies on an annualized basis within three years, with $55 million of one-time costs incurred over that time period. The transaction is subject to regulatory approvals and other customary closing conditions and is expected to close by September 2021. Kessler continued, “We look forward to welcoming the talented Further family to our Purple culture, and to working together to deliver remarkable results to our members, clients, partners and expanded team.”

Advisors

Willkie Farr & Gallagher LLP is serving as legal counsel and Perella Weinberg Partners LP is serving as exclusive financial advisor to HealthEquity. Stella has engaged Taft Stettinius & Hollister LLP for legal counsel and Wells Fargo Securities as exclusive financial advisor.  

About HealthEquity

HealthEquity and its subsidiaries administers Health Savings Accounts (HSAs) and other consumer-directed benefits for our more than 12 million accounts in partnership with employers, benefits advisors, and health and retirement plan providers who share our mission to connect health and wealth and value our culture of remarkable “Purple” service. For more information, visit www.healthequity.com.

About Further 

Headquartered in Eagan, Minn., Further provides health savings accounts (HSAs), flexible spending accounts, (FSAs), health reimbursement arrangements (HRAs), voluntary employee beneficiary association (VEBA) accounts and commuter benefit and custodian services. Serving large corporations, small businesses, labor unions, retirees, and groups in the public sector, Further guides account holders across the United States in saving and spending wisely on their health care. Further is an IRS-approved nonbank trustee through the U.S. Department of Treasury. For more information, visit: www.hellofurther.com

Forward-looking statements

This press release contains “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, including but not limited to, statements regarding our industry, business strategy, plans, goals and expectations concerning our markets and market position, product expansion, future operations, expenses and other results of operations, revenue, margins, profitability, future efficiencies, tax rates, capital expenditures, liquidity and capital resources and other financial and operating information. When used in this discussion, the words “may,” “believes,” “intends,” “seeks,” “anticipates,” “plans,” “estimates,” “expects,” “should,” “assumes,” “continues,” “could,” “will,” “future” and the negative of these or similar terms and phrases are intended to identify forward-looking statements in this press release.

Forward-looking statements reflect our current expectations regarding future events, results or outcomes. These expectations may or may not be realized. Although we believe the expectations reflected in the forward-looking statements are reasonable, we can give you no assurance these expectations will prove to be correct. Some of these expectations may be based upon assumptions, data or judgments that prove to be incorrect. Actual events, results and outcomes may differ materially from our expectations due to a variety of known and unknown risks, uncertainties and other factors. Although it is not possible to identify all of these risks and factors, they include, among others, risks related to the following:

• the impact of the COVID-19 pandemic on the Company, its operations and its financial results;
• our ability to realize the anticipated financial and other benefits from combining the operations of Further with our business in an efficient and effective manner;
• our ability to compete effectively in a rapidly evolving healthcare and benefits administration industry;
• our dependence on the continued availability and benefits of tax-advantaged health savings accounts and other consumer-directed benefits;
• our ability to realize the anticipated financial and other benefits to the Company from acquiring Further;
• our ability to successfully identify, acquire and integrate additional portfolio purchases or acquisition targets;
• the significant competition we face and may face in the future, including from those with greater resources than us;
• our reliance on the availability and performance of our technology and communications systems;
• recent and potential future cybersecurity breaches of our technology and communications systems and other data interruptions, including resulting costs and liabilities, reputational damage and loss of business;
• the current uncertain healthcare environment, including changes in healthcare programs and expenditures and related regulations;
• our ability to comply with current and future privacy, healthcare, tax, investment advisor and other laws applicable to our business;
• our reliance on partners and third-party vendors for distribution and important services;
• our ability to develop and implement updated features for our technology and communications systems and successfully manage our growth;
• our ability to protect our brand and other intellectual property rights; and
• our reliance on our management team and key team members.

For a detailed discussion of these and other risk factors, please refer to the risks detailed in our filings with the Securities and Exchange Commission, including, without limitation, our most recent Annual Report on Form 10-K and subsequent periodic and current reports. Past performance is not necessarily indicative of future results. We undertake no intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Forward-looking statements should not be relied upon as representing our views as of any date subsequent to the date of this press release.

Investor Relations Contact:	Media Relations Contact:
Richard Putnam	Amy Cerny
801-727-1209	801-508-3237
[email protected]	[email protected]
Stella Health Contact:
Jim McManus
651-662-2882
[email protected]